隆平高科：拟转让华智生物合计25.3797%股权

Core Viewpoint - Longping High-Tech (隆平高科) announced a strategic decision to optimize resource allocation and focus on core business development and research innovation by transferring a total of 25.3797% equity in Huazhi Biotechnology Co., Ltd. for a total price of 146.982540 million yuan [1] Group 1 - The company aims to enhance its competitiveness and sustainable operational capacity through this equity transfer [1] - The equity transfer involves Longping High-Tech and its wholly-owned subsidiary Guangxi Hengmao Agricultural Technology Co., Ltd. entering into a share transfer agreement with CITIC Agricultural Technology Co., Ltd. [1] - After the completion of the transaction, the company and Guangxi Hengmao will hold a combined 5.0001% equity in Huazhi Biotechnology [1]